Regulation of D2 and D3 Receptors in Transfected Cells by Agonists and Antagonists

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 443-446

  Burris, Kevin D ^a   Fausing, Susanne M ^a   Molinoff, Perry B ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956777917     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60783-8     Document Type: Article

References (5)

1. Jenner P., and Marsden C.D. Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology 26 (1987) 931-940
2. Filtz T.M., Artymyshyn R.P., Guan W., and Molinoff P.B. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol. Pharmacol 44 (1993) 371-379
3. Filtz T.M., Guan W., Artymyshyn R.P., Pacheco M., Ford C., and Molinoff P.B. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther 271 (1994) 1574-1582
4. Boundy V.A., Pacheco M.A., Guan W., and Molinoff P.B. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in HEK 293 cells. Mol. Pharmacol 48 (1995) 956-964
5. Cox B.A., Rosser M.P., Kozlowski M.R., Duwe K.M., Neve R.L., and Neve K.A. Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse 21 (1995) 1-9